Loading...

ZIVO Bioscience, Inc.

ZIVOW•NASDAQ
Healthcare
Biotechnology
$0.18
$-0.23(-56.52%)

ZIVO Bioscience, Inc. (ZIVOW) Stock Overview

Explore ZIVO Bioscience, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B

Score: 65.6/100

Key Financials

Market Cap646K
P/E Ratio-3.10
EPS (TTM)N/A
ROE10.02%
Fundamental Analysis

AI Price Forecasts

1 WeekN/A
1 MonthN/A
3 Months$1.84
1 Year Target$1.14

ZIVOW Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of ZIVO Bioscience, Inc. (ZIVOW) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $1.14.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -3.10 and a market capitalization of 646K. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Stats data is not available for ZIVOWStats details for ZIVOW are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Analyst Recommendations data is not available for ZIVOWAnalyst Recommendations details for ZIVOW are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Company Profile

ZIVO Bioscience, Inc., a research and development company, engages in licensing and selling natural bioactive ingredients derived from its proprietary algae cultures to animal, human, and dietary supplement and medical food manufacturers. The company operates in the biotech and agtech sectors, with an intellectual property portfolio comprising proprietary algal and bacterial strains, biologically active molecules and complexes, production techniques, cultivation techniques, and patented or patent-pending inventions for applications in human and animal health. Its products indications include poultry gut health, bovine mastitis, canine joint health, human immune modification, algal biomass for human consumption, and biomass for supporting skin health / anti-aging. The company was formerly known as Health Enhancement Products, Inc. and changed its name to ZIVO Bioscience, Inc. in October 2014. ZIVO Bioscience, Inc. is headquartered in Bloomfield Hills, Michigan.

CEO

John Bernard Payne

Employees

7

Headquarters

21 East Long Lake Road, Bloomfield Hills, MI

Founded

1970

Frequently Asked Questions

;